Omega Therapeutics Inc - OMGA Income before deduction of interest, taxes and amortization
Omega Therapeutics is developing a precision gene control ecosystem, establishing patent protection for partnerships with pharmaceutical behemoths. Operating income dynamics show that the metric has reached the level of . The company is currently in the pre-revenue stage, where laboratory expansion is temporarily increasing costs. At the same time, its status as a scientific leader in epigenetics opens prospects for a breakthrough in oncology therapy.
Summary analytical data breakdowns for Omega Therapeutics, Inc. (OMGA)
- market price and analyst price targets:
- issuer market value details:
- book capitalization information:
- company total debt and liquidity indicators:
Debt to Capital Omega Therapeutics|OMGA - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Omega Therapeutics Inc|OMGA - Company Aggregate Debts|Debts to Book Capitalization Omega Therapeutics|OMGA - Company Long-Term Debt|Current Liabilities Omega Therapeutics|Immediate Liquidity omegatherapeutics.com
- financial results and valuation multiples details:
OMGA - Net Income|Projected Future Earnings Omega Therapeutics|OMGA - Price to Earnings Ratio|Market Cap to Future Earnings Ratio omegatherapeutics.com|OMGA - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Omega Therapeutics|OMGA - Operating profit EBITDA|Net earnings per share for the last 12 months Omega Therapeutics|OMGA - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months omegatherapeutics.com|OMGA - Earnings per share growth in current year|Expected net earnings per share growth next year Omega Therapeutics
Summary company analytics:OMGA (Omega Therapeutics Corp)
Omega Therapeutics is investing significant resources into recruiting leading biologists to develop breakthrough epigenetic therapies. This indicator captures net cash flow from operating activities, measuring the business's actual ability to generate cash before depreciation and taxes, which allows for an assessment of financial stability via total EBITDA for the period.
Competitors of Omega Therapeutics (OMGA)
Operating profit EBITDA Tempus TEM|QGEN: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization IONS (ionispharma.com)|RGEN (Repligen) - Operating profit before deduction of amortization|RNA: Company profit before taxes, interest and amortization|CRSP (CRISPR Therapeutics Corp) - Operating profit EBITDA|WGS: Income before deduction of interest, taxes and amortization|Operating profit EBITDA RARE|BEAM - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Sarepta SRPT|Income before deduction of interest, taxes and amortization TWST|10x Genomics Corp - Operating profit EBITDA|NTLA - Operating profit EBITDA|Stoke Therapeutics (STOK) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization BLFS (biolifesolutions.com)|WVE (Wave Life Sciences Ltd.) - Operating profit EBITDA|Profit before interest, taxes and amortization Maze Therapeutics, Inc. MAZE|Operating profit before deduction of amortization SION (Sionna Pharma)|Operating profit EBITDA Prime Medicine Bio (PRME)|Taysha Gene Therapies - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization QURE (uniqure.com)|MeiraGTx - Operating profit EBITDA|Operating income before deduction of amortization REGENXBIO Inc RGNX|SLDB: Operating profit EBITDA|Operating profit before deduction of amortization Ocugen Pharma|Profit before payment of interest, taxes and amortization Pacific Biosciences|benitec.com (BNTC) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Design Therapeutics, Inc. (DSGN)|RCKT - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization 4D Molecular Therapeutics Inc FDMT|LXEO - Operating profit before deduction of amortization|Korro Bio, Inc - Operating profit EBITDA|Operating profit before depreciation charges editasmedicine.com (EDIT)|SLN: Operating profit EBITDA|ProQR Therapeutics (PRQR) - Operating profit EBITDA|CDXS (Codexis Inc) - Operating profit EBITDA|Operating profit before amortization SGMO (Sangamo BioSciences)|Profit before payment of interest, taxes and amortization Nautilus Biotechnology (NAUT)|metagenomi.co - Operating profit before amortization|Operating profit EBITDA DTIL (Precision BioSciences, Inc.)|Operating profit EBITDA Generation Bio Co GBIO|BOLD - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Exicure, Inc.|imunon.com (IMNN) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization Phio Pharmaceuticals Corp.|MBIO (Mustang Bio Inc) - Operating profit EBITDA|Profit before interest, taxes and amortization TransCode RNAZ|Operating profit EBITDA BNGO|Applied DNA Corp (APDN) - Operating profit before depreciation charges|Operating profit EBITDA BLUE (bluebird bio, Inc.)|Operating profit EBITDA ImmunoPrecise Antibodies Ltd IPA|OMIC: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization RGLS (Regulus Therapeutics, Inc.)|SYRS (Syros) - Operating profit before deduction of amortization|TBIO: Company profit before taxes, interest and amortization|TCON (TRACON Pharmaceuticals) - Operating profit EBITDA|UBX: Income before deduction of interest, taxes and amortization
